Virginia Economic Review

Recent major biopharmaceutical announcements have sent a clear signal from the industry: Virginia is the future of biopharma manufacturing.

States, nations, and any municipality can build and tout their critical infrastructure that, on the surface, may appear second to none. Think: thriving, automated food and agriculture ecosystems. Sprawling office buildings outfitted with remote smart sensors. Unflappable financial markets.